A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humans

Nature Medicine

Volumn 6, Issue 3, 2000, Pages 265-270

  Paton, Adrienne W ^a   Morona, Renato ^b   Paton, James C ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLOBOTRIAOSYLCERAMIDE; OLIGOSACCHARIDE; PROBIOTIC AGENT; RECEPTOR; SHIGA TOXIN; STREPTOMYCIN;

ADSORPTION; ANIMAL MODEL; ARTICLE; DYSENTERY; ESCHERICHIA COLI; GENE; GRAM NEGATIVE INFECTION; MOUSE; NEISSERIA GONORRHOEAE; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMALS; BACTERIAL TOXINS; CARBOHYDRATE SEQUENCE; CLONING, MOLECULAR; DYSENTERY, BACILLARY; ENTEROTOXINS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; ESCHERICHIA COLI PROTEINS; GALACTOSYLTRANSFERASES; GUANYLATE CYCLASE; HUMANS; MICE; MOLECULAR SEQUENCE DATA; RECEPTORS, PEPTIDE; RECOMBINANT PROTEINS; RECOMBINATION, GENETIC; SHIGA TOXINS; SHIGELLA DYSENTERIAE;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA; NEISSERIA GONORRHOEAE; NEISSERIA MENINGITIDIS; SHIGELLA DYSENTERIAE;

EID: 0034059721     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/73111     Document Type: Article

References (37)

1. O'Brien, A.D. & Holmes, R.K. Shiga and shiga-like toxins. Microbiol. Rev. 51, 206-220 (1987).
2. Karmali, M.A. Infection by verocytotoxin-producing E. coli. Clin. Microbiol. Rev. 2, 15-38 (1989).
3. Nataro, J.P. & Kaper, J.B. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11, 142-201 (1998).
4. Paton, J.C. & Paton, A.W. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin. Microbiol. Rev. 11, 450-479 (1998).
5. Lingwood, C.A. Role of verotoxin receptors in pathogenesis. Trends Microbiol. 4, 147-153 (1996).
6. DeGrandis, S., Law, H., Brunton, J., Gyles, C. & Lingwood, C.A. Globotetraosyl ceramide is recognized by the pig edema disease toxin. J. Biol. Chem. 264, 12520-12525 (1989).
7. Paton, A.W. et al. Molecular microbiological investigation of an outbreak of hemolytic uremic syndrome caused by dry fermented sausage contaminated with Shiga-like toxin-producing Escherichia coli. J. Clin. Microbiol. 34, 1622-1627 (1996).
8. Paton, A.W., Woodrow, M.C., Doyle, R.M., Lanser, J.A & Paton, J.C. Molecular characterization of a Shiga-toxigenic Escherichia coli O113:H21 strain lacking eae responsible for a cluster of cases of hemolytic-uremic syndrome. J. Clin. Microbiol. 37, 3357-3361 (1999).
9. Wakarchuk, W.W. et al. Structure of an alpha-2,6-sialylated lipooligosaccharide from Neisseria meningitidis immunotype L1. Eur. J. Biochem. 254, 626-633 (1998).
10. Mandrell, R.E. & Apicella, M.A. Lipooligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host modification of LOS. Immunobiology 187, 382-402 (1993).
11. Risberg, A. et al. Structural analysis of the lipopolysaccharide oligosaccharide epitopes expressed by a capsule deficient strain of Haemophilus influenzae Rd. Eur. J. Biochem. 261, 171-180 (1999).
12. Masoud, H., Moxon, E.R., Martin, A., Krajcarski, D. & Richards, J.C. Structure of the variable and conserved lipopolysaccharide oligosaccharide epitopes expressed by Haemophilus influenzae serotype b strain Eagan. Biochemistry 36, 2091-2103 (1997).
13. Cotschlich, E.C. Genetic locus for the biosynthesis of the variable portion of Neisseria gonorrhoeae lipopolysaccharide. J. Exp. Med. 180, 2181-2190 (1994).
14. Yang, Q.-L. & Gotschlich, E.C. Variation of gonococcal lipooligosaccharide structure is due to alterations in poly-G tracts in lgt genes encoding glycosyl transferases. J. Exp. Med 183, 323-327 (1996).
15. Jennings, M.P., Hood, D.W., Peak, I.R., Virji, M. & Moxon, E.R. Molecular analysis of a locus for the biosynthesis and phase-variable expression of the lacto-N-neotetraose terminal lipopolysaccharide structure in Neisseria meningitidis. Mol. Microbiol. 18, 729-740 (1995).
16. Heinrichs, D.E., Yethon, J.A., Amor, P.A. & Whitfield, C. The assembly system for the outer core portion of R1 - and R4-type lipopolysaccharides of Escherichia coli. J. Biol. Chem. 273, 29497-29505 (1998).
17. Lindgren, S.W., Melton, A.R. & O'Brien, A.D. Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model. Infect. Immun. 61, 3832-3842 (1993).
18. Armstrong, G.D., Fodor, E. & and Vanmaele, R. Investigation of Shiga-like toxin binding to chemically synthesized oligosaccharide sequences. J. Infect. Dis. 164, 1160-1167 (1991).
19. Takeda, T., Yoshino, K., Adachi, E., Sato, Y. & Yamagata, K. In vitro assessment of a chemically synthesized Shiga toxin receptor analog attached to chromosorb P (Synsorb Pk) as a specific absorbing agent of Shiga toxin 1 and 2. Microbiol. Immunol. 43, 331-337 (1999).
20. Rogers, J.E., Armstrong, G. & O'Brien, A.D. Abstract V149/VII, 114 (3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-producing Escherichia coli Infections, Baltimore, Maryland, June, 1997). (Lois Joy Galler Foundation for Hemolytic Uremic Syndrome, Melville, New York, 1997).
21. Armstrong, G.D. et al. A phase I study of chemically synthesized verotoxin (Shiga-like toxin) Pk-trisaccharide receptors attached to chromosorb for preventing hemolytic-uremic syndrome. J. Infect. Dis. 171, 1042-1045 (1995).
22. Liljeqvist, S. & Stahl, S. Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines. J. Biotech. 73, 1-33 (1999).
23. Clements, J.D., Hartzog, N.M. & Lyon, F.L. Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens. Vaccine 6, 269-277 (1988).
24. Moran, A.P., Prendergast, M.M. & Appelmelk, B.J. Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease. FEMS Immunol. Med. Microbiol. 16, 105-115 (1996).
25. Maniatis, T., Fritsch, E.F. & Sambrook, J. in Molecular cloning: A Laboratory Manual p. 68 (Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1982).
26. Darveau, R.P. & Hancock, R.E. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonos aeruginosa and Salmonella typhimurium strains. J. Bacteriol. 155, 831-838 (1983).
27. Morona, R., Brown, M.H., Yeadon, J., Heuzenroeder, M.W. & Manning, P.A. Effect of lipopolysaccharide core synthesis mutations on the production of Vibrio cholerae O-antigen in Escherichia coli K-12. FEMS Microbiol. Lett. 663, 279-285 (1991).
28. Klauser, T., Pohlner, J. & Meyer, T. F. Extracellular transport of cholera toxin B subunit using Neisseria IgA protease beta-domain: conformation-dependent outer membrane translocation. EMBO J. 9, 1991-1999 (1990).
29. Wadolkowski, E.A., Burris, J.A. & O'Brien, A.D. Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect. Immun. 58, 2438-2445 (1990).
30. Wadolkowski, E.A., Sung, L.M., Burris, J.A., Samuel, J.A. & O'Brien, A.D. Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect. Immun. 58, 3959-3965 (1990).
31. O'Brien, A.D. et al. Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. Science 226, 694-696 (1984).
32. Yanisch-Perron, C., Vieira, J. & Messing, J. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13 mp18 and pUC19 vectors. Gene 33, 103-119 (1985).
33. Paton, A.W., Paton, J.C. & Manning, P.A. Polymerase chain reaction amplification, cloning and sequencing of variant Escherichia coli Shiga-like toxin type II operons. Microb. Pathog. 15, 77-82 (1993).
34. Paton, A.W., Beutin, L. & Paton, J.C. Heterogeneity of the amino-acid sequences of Escherichia coli Shiga-like toxin type-1 operons. Gene 153, 71-74 (1995).
35. Ito, H., Terai, A., Kurazono, H., Takeda, Y. & Nishibuchi, M. Cloning and nucleotide sequencing of Vero toxin 2 variant genes from E. coli O91:H21 isolated from a patient with HUS. Microb. Pathogen. 8, 47-60 (1990).
36. Jobling, M.G. & Holmes, R.K. Construction of vectors with the p15a replicon, kanamycin resistance, inducible lacZα and pUC18 or pUC19 multiple cloning sites. Nucleic Adds Res. 18, 5315-5316 (1990).
37. Vinogradov, E.V. et al. The structures of the carbohydrate backbones of the lipopolysaccharides from Escherichia coli rough mutants F470 (R1 core type) and F576 (R2 coretype). Eur. J. Biochem. 261, 629-639 (1999).